Zhengye Biotechnology Market Risk Adjusted Performance
| ZYBT Stock | | | 0.75 -0.03 -3.85% |
Zhengye Biotechnology market risk adjusted performance lookup summarizes this and related technical indicators for Zhengye Biotechnology Holding. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Use
Your Current Watchlist to better understand diversified portfolio construction. Broader allocation clarity strengthens diversification analysis. This includes a position in Zhengye Biotechnology Holding inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
Zhengye Biotechnology Holding has current Market Risk Adjusted Performance of
-0.75.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.75 | |
| ER[a] | = | Expected return on investing in Zhengye Biotechnology |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Zhengye Biotechnology Market Risk Adjusted Performance Peers Comparison
Zhengye Market Risk Adjusted Performance Relative To Other Indicators
Zhengye Biotechnology Holding is rated
below average. in market risk adjusted performance category among its top compatitors. It is currently under evaluation. in maximum drawdown category among its top compatitors .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.